Health Canada — Medical Devices · Canada · 2017-03-24 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Diasorin Molecular have recently received customer complaints regarding IB0900G Lot# 32574 and 32865 producing strong common ag bands with no bands for glycoprotein G1 and G2. As a consequence, the lack of G1 and G2 bands has led to an increase in equivocal results.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.